with a trial in advanced melanoma anticipated Pharmaceuticals Inc PPHM NASDAQ to initiate in the near future.
The symbol for Peregrine Pharmaceuticals Inc. in NASDAQ is: PPHM.
As of July 2014, the market cap for Peregrine Pharmaceuticals Inc. (PPHM) is $283,150,943.64.